FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32639411000001100: Rasagiline 1mg tablets (Creo Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-May 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
99642701000001117 Rasagiline 1mg tablets (Creo Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
99642801000001114 Rasagiline 1mg tablets (Creo Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rasagiline 1mg tablets (Creo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Creo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Creo Pharma Ltd) Is a Product containing precisely rasagiline 1 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Creo Pharma Ltd) Has active ingredient Rasagiline false Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Creo Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Creo Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Creo Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Creo Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Creo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rasagiline true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Creo Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Creo Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Creo Pharma Ltd) Has specific active ingredient Rasagiline true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Creo Pharma Ltd) Has basis of strength substance Rasagiline true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rasagiline 1mg tablets (Creo Pharma Ltd) 28 tablet 4 x 7 tablets Has AMP True Rasagiline 1mg tablets (Creo Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start